Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Total Hip Arthroplasty (THA): full-pipeline trial registry
2 of 3 indexed Total Hip Arthroplasty (THA) trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Total Hip Arthroplasty (THA): 3 US clinical trials tracked, 2 recruiting.
Total Hip Arthroplasty (THA) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Smith & Nephew, running 1 of these trials.
Enrollment posture brief
Registry condition total-hip-arthroplasty-tha
OPEN 2 | RECR 67% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Total Hip Arthroplasty (THA) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Total Hip Arthroplasty (THA) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Total Hip Arthroplasty (THA) is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
Rush University Medical Center
NCT07020312
Suzetrigine in Total Hip Arthroplasty
Hospital for Special Surgery, New York
NCT07226700
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Smith & Nephew
NCT06564636
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Total Hip Arthroplasty (THA) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Total Hip Arthroplasty (THA) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Total Hip Arthroplasty (THA) page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Total Hip Arthroplasty (THA) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Smith & Nephew sponsors the most Total Hip Arthroplasty (THA) trials on record, review their full trial history before evaluating a specific study. See Smith & Nephew's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Total Hip Arthroplasty (THA) condition card totals 3 registered trials; most-linked intervention CATALYSTEM; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.